Recent News

• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
• 05.29.2025 - Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
• 05.14.2025 - Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
• 05.14.2025 - Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
• 05.08.2025 - Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
• 05.08.2025 - Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Recent Filings

• 05.23.2025 - EFFECT Notice of Effectiveness
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 8-K Current report
• 05.08.2025 - S-3 Registration statement under Securities Act of 1933
• 05.07.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors